To Define the Attributes of a Novel Theranostic Nanoparticle Dl-N2 to Targeted Integrin Αvβ3 Network in Cholangiocarcinoma(3/3)

Pharmacology, Toxicology and Pharmaceutical Science

1. Integrin 100%
2. Bile Duct Carcinoma 100%
3. Nanoparticle 100%
4. Malignant Neoplasm 40%
5. Cancer Growth 40%
6. Programmed Cell Death 40%
7. Growth Factor 20%
8. Molecular Target 20%
9. Receptor 20%
10. Cytotoxicity 20%